文献速递瓣膜病与结构性心脏病

人工智能增强心电图预测反流性瓣膜性心脏病:一项国际研究

Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study.
PubMed 文献 · Eur Heart J · 2025-01-01

模型在内部测试集中预测未来显著反流的C指数分别为二尖瓣0.774、主动脉瓣0.691、三尖瓣0.793,最高风险四分位较低风险四分位的风险比显著升高,外部验证结果一致。

要点

  • AI-ECG模型可预测未来显著二尖瓣、三尖瓣和主动脉瓣反流,内部测试C指数0.691-0.793。
  • 最高风险四分位未来显著二尖瓣反流风险比7.6,三尖瓣9.9,主动脉瓣3.8。
  • 模型预测与亚临床心脏重构相关,可用于指导高风险患者超声随访。

核心结论

  • AI-ECG模型可诊断并预测未来显著反流性瓣膜性心脏病,并在跨国、种族不同队列中验证。

主要发现

  • 内部测试集中,模型预测未来显著二尖瓣反流的C指数为0.774(95%CI 0.753-0.792),主动脉瓣反流为0.691(95%CI 0.657-0.720),三尖瓣反流为0.793(95%CI 0.777-0.808)。
  • 上述发现在跨国外部测试集中得到确认,影像关联分析显示AI-ECG预测与亚临床心腔重构相关。

临床怎么用

  • AI-ECG模型可用于指导有未来反流性瓣膜性心脏病风险患者的超声心动图监测,促进早期发现和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Valvular heart disease (VHD) is a significant source of morbidity and mortality, though early intervention can improve outcomes. This study aims to develop artificial intelligence-enhanced electrocardiography (AI-ECG) models to diagnose and predict future moderate or severe regurgitant VHDs (rVHDs), including mitral regurgitation (MR), tricuspid regurgitation (TR), and aortic regurgitation (AR). METHODS: The AI-ECG models were developed in a data set of 988 618 ECG and transthoracic echocardiogram pairs from 400 882 patients from Zhongshan Hospital, Shanghai, China. The AI-ECG models used a residual convolutional neural network with a discrete-time survival loss function. External evaluation was performed in outpatients from a secondary care data set from Beth Israel Deaconess Medical Center, Boston, USA, consisting of 34 214 patients with linked echocardiography. RESULTS: In the internal test set, the AI-ECG models accurately predicted future significant MR [C-index 0.774, 95% confidence interval (CI) 0.753-0.792], AR (0.691, 95% CI 0.657-0.720), and TR (0.793, 95% CI 0.777-0.808). In age- and sex-adjusted Cox models, the highest risk quartile had a hazard ratio (HR) of 7.6 (95% CI 5.8-9.9, P < .0001) for risk of future significant MR, compared with the lowest risk quartile. For future AR and TR, the equivalent HRs were 3.8 (95% CI 2.7-5.5) and 9.9 (95% CI 7.5-13.0), respectively. These findings were confirmed in the transnational external test set. Imaging association analyses demonstrated AI-ECG predictions were associated with subclinical chamber remodelling. CONCLUSIONS: This study developed AI-ECG models to diagnose and predict rVHDs and validated the models in a transnational and ethnically distinct cohort. The AI-ECG models could be utilized to guide surveillance echocardiography in patients at risk of future rVHDs, to facilitate early detection and intervention.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Liang Y, Sau A, Zeidaabadi B, et al. Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study. Eur Heart J. 2025. PMID: 40669514. doi:10.1093/eurheartj/ehaf448

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。